Impact of age and comorbidity on cause and outcome in community-acquired pneumonia.
about
Efficacy of PPV23 in Preventing Pneumococcal Pneumonia in Adults at Increased Risk--A Systematic Review and Meta-AnalysisWhich individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal diseaseIs COPD associated with increased mortality and morbidity in hospitalized pneumonia? A systematic review and meta-analysisMicrobial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance PatternsThe aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature reviewAge-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study.Bacteriological assessment of healthcare-associated pneumonia using a clone library analysisEffect of 23-Valent Pneumococcal Polysaccharide Vaccine Inoculated During Anti-Cancer Treatment Period in Elderly Lung Cancer Patients on Community-Acquired Pneumonia Hospitalization: A Nationwide Population-Based Cohort StudyPharmacotherapy for community-acquired pneumonia in the elderly.Community-acquired pneumonia related to intracellular pathogens.Clinical Management of Community Acquired Pneumonia in the Elderly Patient."You need to be an advocate for yourself": Factors associated with decision-making regarding influenza and pneumococcal vaccine use among US older adults from within a large metropolitan health system.South African guideline for the management of community-acquired pneumonia in adults.Prognostic factors for mortality due to pneumonia among adults from different age groups in Singapore and mortality predictions based on PSI and CURB-65.Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia.Seasonality of pathogens causing community-acquired pneumonia.Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during 2 influenza seasons.The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia.Nursing home-acquired pneumonia presenting at the emergency department.Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia.[Prevention in the elderly: position paper on pneumococcal vaccinations. Results of an expert workshop on 15 November 2013 in Cologne, Germany].Naso- and oropharyngeal bacterial carriage in nursing home residents: Impact of multimorbidity and functional impairment.Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.How to manage Pseudomonas aeruginosa infections.Effectiveness of 23-valent pneumococcal polysaccharide vaccine on elderly long-term cancer survivors: a population-based propensity score matched cohort study.Six underlying health conditions strongly influence mortality based on pneumonia severity in an ageing population of Japan: a prospective cohort study.Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia.Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging.Age-related risk factors for bacterial aetiology in community-acquired pneumonia
P2860
Q26772119-CBDA2D6B-90BB-4C4D-A8B4-B4755BAA4757Q26798305-357DB199-AC77-47D9-9700-4B51B46A624CQ26801413-FA91A19B-3A72-4429-AEBB-EB50A7D65C1BQ28069467-B8AAD67C-5720-48EA-B211-7273B3096CC5Q33701151-5999C352-F839-4484-B370-73DE557B8BE0Q33816163-86DF14E4-9C41-4C9E-8312-6F0DB8DC1AD2Q35432136-E9F5DA83-B3B2-4CD5-A59B-9219E8BC75B3Q35858250-BCD6CFF4-2298-47F4-B28C-69EA08447F87Q38731918-0492C452-D1E7-40D4-B738-1E480D03366CQ38859130-A718AA24-49FA-4B6E-BE91-F5429A9C7E25Q38969066-120E0BD6-35C8-4A51-99B8-ECE0DE574954Q39393976-BED5BCE0-C811-4C5F-97DB-6887E856486EQ39455917-92E76656-11CD-48B7-BF60-2847FA4AA2BFQ40084213-755E4580-6D7F-4270-A272-9AE0F2B01FC5Q40102140-836EFF07-9A20-4D99-B100-69869B5F96CBQ40369631-6B78930C-FCA2-46D6-AF0A-A1545D78B27EQ40438234-BB8C5FCB-85BE-497A-A96B-C323FF35B5BCQ40618862-DB431429-8D6F-49B9-B36A-75B846F8559DQ40764625-5A0C49E2-1D36-44CD-832A-0744B9B92B02Q41044146-19EE5321-E0BF-41F6-8F0D-470085EADD4EQ43447838-1BD3AEF4-26DB-434B-A5AA-98565D137328Q47205605-C98DC4D4-B2CE-476D-BC14-3B79F6669883Q53516441-0A85FC1C-1B62-467D-888D-24C9E50EFB2BQ54977074-D3C660AA-0606-4F32-862D-EC77E8AE182CQ54982512-09C81901-2066-456A-A296-70A4009EDD70Q54984962-8A14912E-74A0-4410-8500-95D4C894A83AQ55035257-4CD63EB3-3166-4E89-900A-A742FEE24944Q55431323-A95B8461-CDE3-47D3-A74C-925FE470DD2FQ57237653-386B4057-7B01-4EB0-9349-48123A495640
P2860
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia.
@en
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia.
@nl
type
label
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia.
@en
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia.
@nl
prefLabel
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia.
@en
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia.
@nl
P2093
P50
P356
P1433
P1476
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia.
@en
P2093
Albert Gabarrús
Antoni Torres
Josep Mensa
Santiago Ewig
P304
P356
10.1378/CHEST.13-0062
P407
P577
2013-09-01T00:00:00Z